This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents. Top assignee: Genentech, Inc.. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: The Innovative Contributions of Dan Lu
Introduction
Dan Lu is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of immunology, particularly in the treatment of B-cell proliferative disorders. With a total of 2 patents to his name, his work has the potential to impact many lives.
Latest Patents
Dan Lu's latest patents focus on methods of using anti-CD79b immunoconjugates. These patents provide innovative methods for treating B-cell proliferative disorders, specifically Follicular Lymphoma and Diffuse Large B-Cell Lymphoma. The immunoconjugates he developed comprise anti-CD79b antibodies combined with additional therapeutic agents, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Dan Lu has worked with leading companies in the pharmaceutical industry, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with some of the brightest minds in the field, further enhancing his expertise and contributions.
Collaborations
Dan Lu has had the opportunity to work alongside talented individuals such as Andrew G. Polson and Shang-Fan Yu. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in his area of expertise.
Conclusion
Dan Lu's work in the field of immunology, particularly through his patents on anti-CD79b immunoconjugates, highlights his role as a significant inventor. His contributions to the treatment of B-cell proliferative disorders demonstrate the impact of innovation in medicine.